Johan Jendle

4.4k total citations
108 papers, 2.5k citations indexed

About

Johan Jendle is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Johan Jendle has authored 108 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Endocrinology, Diabetes and Metabolism, 30 papers in Surgery and 22 papers in Genetics. Recurrent topics in Johan Jendle's work include Diabetes Management and Research (70 papers), Diabetes Treatment and Management (48 papers) and Pancreatic function and diabetes (29 papers). Johan Jendle is often cited by papers focused on Diabetes Management and Research (70 papers), Diabetes Treatment and Management (48 papers) and Pancreatic function and diabetes (29 papers). Johan Jendle collaborates with scholars based in Sweden, Denmark and United States. Johan Jendle's co-authors include Peter Adolfsson, Zvonko Miličević, Honghua Jiang, Åsa Ericsson, B. E. Karlberg, Ole Torffvit, Vincent Woo, Jorge Luiz Gross, Lawrence Blonde and Jessie L. Fahrbach and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Johan Jendle

102 papers receiving 2.4k citations

Peers

Countries citing papers authored by Johan Jendle

Since Specialization

Citations

This map shows the geographic impact of Johan Jendle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Jendle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Jendle more than expected).

Fields of papers citing papers by Johan Jendle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Jendle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Jendle. The network helps show where Johan Jendle may publish in the future.

Co-authorship network of co-authors of Johan Jendle

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Jendle. A scholar is included among the top collaborators of Johan Jendle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Jendle. Johan Jendle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Recommendations on the Collection of Comparator Measurement Data in the Performance Evaluation of Continuous Glucose Monitoring Systems 2025 ·Journal of Diabetes Science and Technology ·Guido Freckmann, Stefan Pleus, Manuel Eichenlaub, (unknown), Marion Fokkert, Rolf Hinzmann, Johan Jendle, David C. Klonoff, Konstantinos Makris, James H. Nichols, John Pemberton, Elizabeth Selvin, Nam K. Tran, L. Witthauer, Robbert J. Slingerland	8
2	A systematic literature review and meta‐analysis of real‐world evidence on commercially available automated insulin delivery systems in people with type 1 diabetes 2025 ·Diabetes Obesity and Metabolism ·(unknown), Jayne Smith‐Palmer, Erik H. Serné, (unknown), Johan Jendle, Pratik Choudhary, Emanuele Bosi, (unknown), Tim van den Heuvel, Ohad Cohen, Richard F. Pollock	0
3	Clinical assessment and acceptance criteria for continuous glucose monitoring (CGM) system performance: A proposed guideline by the IFCC Working Group on CGM 2025 ·Clinica Chimica Acta ·Stefan Pleus, Manuel Eichenlaub, Pradeep Kumar Dabla, Peter Diem, (unknown), Marion Fokkert, Rolf Hinzmann, Johan Jendle, David C. Klonoff, Jingyi Lu, Konstantinos Makris, Viswanathan Mohan, James H. Nichols, John Pemberton, Elizabeth Selvin, Robbert J. Slingerland, Andreas Thomas, Nam K. Tran, L. Witthauer, Guido Freckmann	0
4	Glycaemic control and pregnancy outcomes with real-time continuous glucose monitoring in gestational diabetes (GRACE): an open-label, multicentre, multinational, randomised controlled trial 2025 ·The Lancet Diabetes & Endocrinology ·(unknown), (unknown), (unknown), Karen Schellong, (unknown), (unknown), Cécile Monod, (unknown), (unknown), Bettina Winzeler, Beatrice Mosimann, (unknown), Tanja Groten, Martina Mittlböck, Johan Jendle, Wolfgang Henrich, Micaela Morettini, Latife Bozkurt, (unknown), Christian Göbl, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
5	MiniMed 780G system performance in older users with type 1 diabetes: Real‐world evidence and the case for stricter glycaemic targets 2025 ·Diabetes Obesity and Metabolism ·(unknown), Simon Heller, David N. O’Neal, Johan Jendle, Tali Cukierman‐Yaffe, Arcelia Arrieta, (unknown), Javier Castañeda, Tim van den Heuvel, Ohad Cohen	4
6	Effects, Safety, and Treatment Experience of Advanced Hybrid Closed-Loop Systems in Clinical Practice Among Adults Living With Type 1 Diabetes 2024 ·Journal of Diabetes Science and Technology ·(unknown), Henrik Imberg, (unknown), (unknown), Johan Jendle, Bengt-Olov Tengmark, Anna Folino, (unknown), Marcus Lind	7
7	Clinical perspective on innovative insulin delivery technologies in diabetes management 2024 ·Frontiers in Endocrinology ·(unknown), Tadej Battelino, Goran Petrovski, Johan Jendle, Beatrix Sármán, Nancy Samir Elbarbary, Damla Gökşen, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
8	The Need for Standardization of Continuous Glucose Monitoring Performance Evaluation: An Opinion by the International Federation of Clinical Chemistry and Laboratory Medicine Working Group on Continuous Glucose Monitoring 2024 ·Journal of Diabetes Science and Technology ·Stefan Pleus, Manuel Eichenlaub, (unknown), Marion Fokkert, Rolf Hinzmann, Johan Jendle, David C. Klonoff, Konstantinos Makris, James H. Nichols, John Pemberton, Elizabeth Selvin, Robbert J. Slingerland, Andreas Thomas, Nam K. Tran, L. Witthauer, Guido Freckmann	8
9	Clinical Performance Evaluation of Continuous Glucose Monitoring Systems: A Scoping Review and Recommendations for Reporting 2023 ·Journal of Diabetes Science and Technology ·Guido Freckmann, Manuel Eichenlaub, Delia Waldenmaier, Stefan Pleus, (unknown), Cornelia Haug, L. Witthauer, Johan Jendle, Rolf Hinzmann, Andreas Thomas, (unknown), Konstantinos Makris, Peter Diem, Nam K. Tran, David C. Klonoff, James H. Nichols, Robbert J. Slingerland	37
10	A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU/UK/US perspective 2023 ·Diabetologia ·Johan Jendle, Peter Adolfsson, Pratik Choudhary, Klemen Dovč, G. Alexander Fleming, David C. Klonoff, Julia K. Mader, Nick Oliver, Jennifer L. Sherr, Jan Šoupal, Lutz Heinemann	14
11	Associations of bolus insulin injection frequency and smart pen engagement with glycaemic control in people living with type 1 diabetes 2023 ·Diabetes Obesity and Metabolism ·Jarl Hellman, Niels Væver Hartvig, Anne Kaas, Jonas Bech Møller, Mads R. Sørensen, Johan Jendle	8
12	A European Cost–Utility Analysis of the MiniMed™ 780G Advanced Hybrid Closed-Loop System Versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People Living with Type 1 Diabetes 2023 ·Diabetes Technology & Therapeutics ·Johan Jendle, (unknown), (unknown), Simona de Portu, Jayne Smith‐Palmer, Richard F. Pollock, Ohad Cohen	9
13	Dapagliflozin as an Adjunct Therapy to Insulin in Patients with Type 1 Diabetes Mellitus: Efficacy and Safety of this Combination 2021 ·touchREVIEWS in Endocrinology ·Johan Jendle, Francisco Javier Ampudia‐Blasco, Martin Füchtenbusch, Paolo Pozzilli	3
14	Real-world cost-effectiveness of insulin degludec in type 1 and type 2 diabetes mellitus from a Swedish 1-year and long-term perspective 2020 ·Journal of Medical Economics ·Johan Jendle, Åsa Ericsson, Bertil Ekman, Stefan Sjöberg, Jens Gundgaard, J. da Rocha Fernandes, Ann‐Charlotte Mårdby, Barnaby Hunt, Samuel J. P. Malkin, Maria Thunander	8
15	Quantifying The Short-Term Impact of Changes In Hba1c, Weight And Insulin Regimen on Health Related Quality-of-Life 2015 ·Value in Health ·Marc Evans, Martin Ridderstråle, (unknown), Mette Bøgelund, (unknown), Aaron C. Ericsson, Johan Jendle	2
16	Glucose Changes and Working Memory in Individuals with Type 1 Diabetes During Air Pressure Changes Simulating Skydiving 2013 ·Diabetes Technology & Therapeutics ·(unknown), A. Westman, (unknown), (unknown), Johan Jendle	1
17	Health status in people with type 2 diabetes on basal-oral therapy is significantly improved with insulin degludec vs insulin glargine 2012 ·UCL Discovery (University College London) ·Johan Jendle, Nick Freemantle, Luigi Meneghini, (unknown), (unknown), (unknown)	2
18	Insulin and GLP-1 analog combinations in type 2 diabetes mellitus: a critical review 2012 ·Expert Opinion on Investigational Drugs ·Johan Jendle, Sherry Martin, Zvonko Miličević	13
19	Evaluating the cost‐effectiveness of reduced mild hypoglycaemia in subjects with Type 1 diabetes treated with insulin detemir or NPH insulin in Denmark, Sweden, Finland and the Netherlands 2011 ·Diabetic Medicine ·William J. Valentine, Johan Jendle, Markku Saraheimo, Birger Thorsteinsson, Richard F. Pollock, Morten Lammert	16
20	Pharmacokinetics of pulmonary insulin in healthy smokers and non-smokers 2001 ·Lund University Publications (Lund University) ·Johan Jendle, (unknown), Á. Callejo Mellén, Per Wollmer, (unknown), Ulf Dahl	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact